Share
Share today's newsletter with a colleague
and get credit if they sign up for SmartBrief.
Referral Count:
0
Story being shared
FDA clears Elekta's latest radiotherapy planning tool
The FDA has cleared Elekta to market Monaco 5, the newest version of its technology used for planning radiation treatments. The system, which is now available commercially in the U.S., combines all of the company's radiation-therapy planning tools into a single unit.
Or we can send an email on your behalf